These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4107815)

  • 1. Structural changes in Clostridium botulinum type E after treatment with boticin S5 1 .
    Ellison JS; Mattern CF; Daniel WA
    J Bacteriol; 1971 Oct; 108(1):526-34. PubMed ID: 4107815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of boticin P produced by Clostridium botulinum.
    Lau AH; Hawirko RZ; Chow CT
    Can J Microbiol; 1974 Mar; 20(3):385-90. PubMed ID: 4132521
    [No Abstract]   [Full Text] [Related]  

  • 3. Boticinogeny and actions of the bacteriocin.
    Anastasio KL; Soucheck JA; Sugiyama H
    J Bacteriol; 1971 Jul; 107(1):143-9. PubMed ID: 4935316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of two boticins.
    Ellison JS; Kautter JA
    J Bacteriol; 1970 Oct; 104(1):19-26. PubMed ID: 4919745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic effect on Clostridium botulinum type E by organisms resembling it.
    Kautter DA; Harmon SM; Lynt RK; Lilly T
    Appl Microbiol; 1966 Jul; 14(4):616-22. PubMed ID: 4288828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, nucleotide sequence, and expression of the gene encoding the bacteriocin boticin B from Clostridium botulinum strain 213B.
    Dineen SS; Bradshaw M; Johnson EA
    Appl Environ Microbiol; 2000 Dec; 66(12):5480-3. PubMed ID: 11097932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructure and characterization of an asporogenic mutant of Clostridium botulinum type E.
    Hawirko RZ; Chung KL; Emeruwa AC; Magnusson AJ
    Can J Microbiol; 1973 Feb; 19(2):281-4. PubMed ID: 4633199
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of spore spheroplasts of Clostridium botulinum and DNA extraction for density gradient centrifugation.
    Durban E; Durban EM; Grecz N
    Can J Microbiol; 1974 Mar; 20(3):353-8. PubMed ID: 4595493
    [No Abstract]   [Full Text] [Related]  

  • 10. Fine structure of protoplasts and L-forms of Clostridium botulinum types A and E.
    Brown GW; Pate JL; Sugiyama H
    J Bacteriol; 1971 Mar; 105(3):1207-10. PubMed ID: 4323294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.
    Eklund MW; Poysky FT; Mseitif LM; Strom MS
    Appl Environ Microbiol; 1988 Jun; 54(6):1405-8. PubMed ID: 2843093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosporium formation in sporulating cells of Clostridium botulinum 78A.
    Stevenson KE; Vaughn RH
    J Bacteriol; 1972 Oct; 112(1):618-21. PubMed ID: 4562412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyricin 7423: a bacteriocin produced by Clostridium butyricum NCIB7423.
    Clarke DJ; Morris JG
    J Gen Microbiol; 1976 Jul; 95(1):67-77. PubMed ID: 956780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1975 Jun; 19(3):167-72. PubMed ID: 1100888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages of Clostridium botulinum.
    Dolman CE; Chang E
    Can J Microbiol; 1972 Jan; 18(1):67-76. PubMed ID: 4110830
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.
    Smith LD
    Appl Microbiol; 1975 Aug; 30(2):319-23. PubMed ID: 169734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI; Cherniavskiĭ VI; Kulakova GS; Iskritskiĭ GV
    Mikrobiol Zh; 1973; 35(3):308-12. PubMed ID: 4598684
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative studies of an asporogenic mutant and a wild type strain of Clostridium botulinum type E 1 .
    Emeruwa AC; Hawirko RZ
    Can J Microbiol; 1972 Jan; 18(1):29-34. PubMed ID: 4551615
    [No Abstract]   [Full Text] [Related]  

  • 19. Compound inhibitory to Clostridium botulinum type E produced by a Moraxella species.
    Kwan PL; Lee JS
    Appl Microbiol; 1974 Feb; 27(2):329-32. PubMed ID: 4595959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria.
    Dajani AS; Wannamaker LW
    J Bacteriol; 1973 May; 114(2):738-42. PubMed ID: 4267533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.